Brainomix 360 Hyperdensity
Overview
Brainomix 360 Hyperdensity is a component of the Brainomix 360 Stroke AI platform, which provides real-time interpretation of brain scans across various modalities, including Non-Contrast CT (NCCT), CT Angiography (CTA), CT Perfusion (CTP), and MRI.
- What it does: Specifically, the Brainomix 360 Hyperdensity feature, as part of the NCCT analysis, calculates the ASPECTS score and highlights regions with hyper- and hypodensities. It also assesses ischemic core based on net water uptake from standard imaging, with results comparable to CT Perfusion and MRI. The software is designed to detect the hyperdense artery sign (HAS), which can indicate a large vessel occlusion (LVO) in acute ischemic stroke patients. It also flags suspected intracranial hemorrhages (ICH).
- Who it is for: This tool is intended for hospital networks and trained clinicians, including stroke specialists, radiologists, and interventionalists, involved in the acute stroke pathway. It is used in care settings where rapid assessment of stroke imaging is critical.
- How it fits a clinical or practice workflow: After a routine NCCT scan is acquired, it is automatically sent to Brainomix for AI-powered analysis, with results delivered to clinicians via PACS, mobile app, email, or web UI within minutes. This aims to streamline workflows, facilitate faster treatment decisions, and improve communication among stroke teams. The mobile app allows for secure access, review, and sharing of images and patient data, and can be used to signal patient eligibility for thrombectomy.
- Notable capabilities: Key capabilities include automated ASPECTS scoring, acute hypodensity heatmap, and the ability to flag suspected LVOs and ICH. It also provides automated quantification of collaterals and core volume assessment from NCCT, which may assist clinical assessment when CTP or MRI are not readily available. The software can also estimate thrombus length on NCCT. Brainomix 360 Stroke is designed to provide real-time smartphone alerts for suspected large vessel occlusions and intracranial hemorrhages.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Automated detection and quantification of brain hyperdensities on CT scans
- AI-powered interpretation of brain scans across NCCT, CTA, CTP, and MRI
- Automated ASPECTS scoring
- Hyperdense Vessel Sign (segmentation + length)
- NCCT Core Volume assessment
- Acute Hypodensity Heatmap
- ICH Detection, Volume, and Mask
- Real-time alerts for suspected Large Vessel Occlusion (LVO) and intracranial hemorrhage (ICH)
- PACS integration
- Mobile app access for results and communication
Use Cases
- Rapid assessment of acute ischemic stroke patients
- Assisting clinicians in making time-sensitive treatment and transfer decisions for stroke patients
- Workflow triage by flagging and communicating suspected positive findings of head NCCT images for LVO or ICH
- Expanding patient access to life-changing treatments like thrombolysis and mechanical thrombectomy
- Supporting imaging-based treatment decisions across the stroke pathway
- Enhancing and standardizing ASPECTS scoring
What Physicians Need to Know
Brainomix 360 Hyperdensity is a powerful tool for rapid stroke assessment, particularly for identifying large vessel occlusions and intracranial hemorrhages from NCCT and CTA scans. Leverage the automated ASPECTS scoring and hypodensity heatmaps for quick initial evaluations. The mobile notification system is crucial for accelerating communication and decision-making within stroke networks, but remember that mobile images are for preview and triage, not primary diagnosis. Integrate the AI-powered insights with your clinical judgment and other patient information for comprehensive treatment decisions. The platform's ability to provide core volume assessment from NCCT can be particularly beneficial in settings where CTP or MRI may not be immediately available.
Brainomix 360 can be deployed on a dedicated physical server, a virtual server, or in a secure cloud environment. Results are delivered directly to clinicians via PACS, mobile app, email, or web UI within minutes of the scan being acquired. It is compliant with the DICOM standard and works with existing enterprise directories, including LDAP, Microsoft AD, and Single Sign-On, with multi-factor authentication. Patient data is pseudonymized and encrypted. The system has been validated for use with Siemens, GE, and Philips scanners.
Details
| Category | Neurology AI, Radiology & Imaging AI |
| Pricing | Unknown — unknown |
| Deployment | Physical server, virtual server, or cloud |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
Unknown AI-estimated Brainomix 360 e-ASPECTS, a component of the Brainomix 360 platform, received FDA clearance as a computer-aided diagnosis (CADx) software device to assist clinicians in assessing and characterizing brain tissue abnormalities using CT image data. Additionally, Brainomix has received FDA clearance for a feature that enables physicians to assess ischemic core volume from non-contrast CT (NCCT) images through the Brainomix 360 Stroke solution. |
| Integrations | |
| EHR | Not specified |
| Specialties | Emergency Medicine, Neurology, Radiology |
What the Web Says
Brainomix 360 Hyperdensity is part of the Brainomix 360 Stroke platform, an AI-powered imaging solution designed to assist clinicians in making faster and more informed treatment decisions for stroke patients. It analyzes non-contrast CT (NCCT) scans to identify hyperdense volumes associated with acute intracranial hemorrhage (ICH) and hyperattenuation in vessels and hypodense regions linked to large vessel occlusion (LVO). The software aims to improve patient outcomes by streamlining workflows, reducing treatment times, and expanding access to life-saving stroke therapies like mechanical thrombectomy.
Overall: PositiveStrengths
- Calculates ASPECTS score and highlights hyper/hypodensities on NCCT.
- Detects large vessel occlusions and intracranial hemorrhages, sending real-time smartphone alerts.
- Reduces door-in-door-out times at primary stroke units and increases mechanical thrombectomy rates.
- Provides results equivalent to CT Perfusion and MRI from standard imaging alone.
- Offers secure access to AI-powered scan results via mobile app, web app, and email, facilitating communication and care coordination.
- Demonstrated high accuracy in identifying acute hemorrhage (97.8%) and large vessel occlusions (91.5%).
Limitations
- Not intended to detect isolated subarachnoid hemorrhage or symmetrical bilateral MCA occlusions.
- Mobile app images are compressed previews and not for diagnostic use beyond notification.
- Does not replace the need for CTA in ischemic stroke workup; it provides workflow prioritization and notification only.
- Should be used as an adjunct to expert interpretation rather than a standalone decision-making tool.
- Accuracy for identifying hyperdense thrombus was lower (69.1%) due to many false positives.
Based on reviews from: Brainomix, accessdata.fda.gov, NeuroNews International, Blackford Analysis, MDPI, Diagnostic and Interventional Cardiology, Oxford University Innovation, Reddit, BioIndustry Association | BIA, MedicalExpo, Medium, PubMed
Last updated: 2026-09-27
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate Brainomix 360 Hyperdensity
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for Brainomix 360 Hyperdensity.
Frequently Asked Questions
Investors who backed Brainomix 360 Hyperdensity
Funded through the company that built this tool.
